Employees Retirement System of Texas’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
WC
LPAM
CSC
2L
ICM
HA
PAIM
Employees Retirement System of Texas's LFCR Position: Q3 2022 in Review
Employees Retirement System of Texas sold out of Lifecore Biomedical (LFCR) in Q3 2022, closing a stake of 170,400 shares — an estimated $1.7M sold.
Employees Retirement System of Texas first reported a position in LFCR in Q3 2021 and held it in 4 quarters. The position peaked at $1.7M in Q2 2022. 86 funds tracked by Wall St. Rank hold LFCR as of Q3 2022.
- Employees Retirement System of Texas reported no remaining Lifecore Biomedical position as of Q3 2022 after selling out during the quarter.
- Employees Retirement System of Texas sold 170,400 Lifecore Biomedical shares in Q3 2022, an estimated $1.7M.
- Employees Retirement System of Texas first reported a position in Lifecore Biomedical in Q3 2021 and held it in 4 quarters.
- Employees Retirement System of Texas's Lifecore Biomedical position peaked at $1.7M in Q2 2022.
- 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2022.
Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.